ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $400 | -10.1% | 15,395 | -0.6% | 0.00% | 0.0% |
Q1 2023 | $445 | -5.3% | 15,495 | -2.5% | 0.00% | 0.0% |
Q4 2022 | $470 | -99.9% | 15,895 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $378,000 | +7.1% | 15,895 | +0.6% | 0.00% | 0.0% |
Q2 2022 | $353,000 | -10.4% | 15,795 | +0.6% | 0.00% | 0.0% |
Q1 2022 | $394,000 | -29.9% | 15,695 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $562,000 | -15.9% | 15,695 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $668,000 | -1.6% | 15,695 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $679,000 | +6.1% | 15,695 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $640,000 | -14.3% | 15,695 | -4.8% | 0.00% | -50.0% |
Q4 2020 | $747,000 | +23.5% | 16,495 | -3.5% | 0.00% | +100.0% |
Q3 2020 | $605,000 | -14.2% | 17,095 | -8.6% | 0.00% | -50.0% |
Q2 2020 | $705,000 | +30.1% | 18,695 | -0.2% | 0.00% | 0.0% |
Q1 2020 | $542,000 | -45.7% | 18,741 | -2.6% | 0.00% | 0.0% |
Q4 2019 | $998,000 | +39.2% | 19,241 | +47.3% | 0.00% | 0.0% |
Q3 2019 | $717,000 | +57.9% | 13,066 | +17.0% | 0.00% | +100.0% |
Q2 2019 | $454,000 | +34.3% | 11,166 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $338,000 | -9.9% | 11,166 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $375,000 | -20.4% | 11,166 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $471,000 | +31.9% | 11,166 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $357,000 | -35.7% | 11,166 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $555,000 | -7.8% | 11,166 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $602,000 | -7.1% | 11,166 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $648,000 | +17.6% | 11,166 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $551,000 | -13.0% | 11,166 | -23.3% | 0.00% | -50.0% |
Q1 2017 | $633,000 | -11.2% | 14,566 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $713,000 | -6.7% | 14,566 | -8.8% | 0.00% | 0.0% |
Q3 2016 | $764,000 | +1.2% | 15,966 | +13.5% | 0.00% | 0.0% |
Q2 2016 | $755,000 | +51.3% | 14,066 | +26.0% | 0.00% | +100.0% |
Q1 2016 | $499,000 | +26.0% | 11,166 | +7.7% | 0.00% | 0.0% |
Q4 2015 | $396,000 | +23.8% | 10,366 | +3.0% | 0.00% | 0.0% |
Q3 2015 | $320,000 | -3.6% | 10,066 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $332,000 | -43.8% | 10,066 | -29.9% | 0.00% | -50.0% |
Q1 2015 | $591,000 | -46.9% | 14,366 | -47.4% | 0.00% | +100.0% |
Q4 2014 | $1,114,000 | +222.0% | 27,332 | +189.5% | 0.00% | 0.0% |
Q3 2014 | $346,000 | -16.6% | 9,442 | +5.5% | 0.00% | 0.0% |
Q2 2014 | $415,000 | +33.4% | 8,953 | +18.3% | 0.00% | 0.0% |
Q1 2014 | $311,000 | +38.8% | 7,566 | +29.0% | 0.00% | 0.0% |
Q4 2013 | $224,000 | – | 5,866 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |